Switching space...
Please wait while we prepare your workspace
Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.
Follow Allegria Therapeutics
FOUNDATION
YEAR2023
YEAR2023
EMPLOYEESN/A
AVERAGE AGEN/A
Jobs
